Skip to main content
. 2023 Jun 1;38(6-7):466–477. doi: 10.1177/08830738231177386

Table 2.

Clinical and Electrophysiological Stages of Rett Syndrome Natural Progression.a

Rett syndrome stage Age Clinical characteristics EEG findings
1. Early onset stagnation stage

6 mo to 2 y Developmental arrest
Changed communication and personality
Diminished play interest
Hand washing stereotypy
Decelerating head growth
Normal
If abnormal: mild background slowing, spike wave discharge in sleep
2. Rapid destructive stage

2 to 4.5 y Developmental regression with autistic traits and dementia
Apraxic/ataxic gait
Loss of hand skills
Onset of seizures and hyperventilation
Normal to mild background slowing
Centrotemporal spike or sharp waves
Poorly formed sleep (loss of non-REM)
Atypical spike and wave discharges enhanced by sleep
3. Pseudostationary/plateau stage


2 y to adulthoodSome patients remain in stage 3 for their entire lives Increased attentiveness and decreased autistic traits
Intellectual disability
Gross motor dysfunction and apraxia
Seizures
Poorly formed posterior dominant rhythm
Low-voltage, poorly reactive, generalized slowing


Poorly formed sleep architecture (absent non-REM)
High-voltage delta and spike wave in sleep
Multifocal spike wave and rhythmic bursts of central delta activity
4. Late motor deterioration stage


>10 y Decrease or loss of mobility
Decreasing seizures
Growth retardation and weight loss
Marked background slowing with fronto-central rhythmic delta
Multifocal spike wave
Generalized slow spike wave in sleep
Epileptiform activity may be absent

Abbreviations: EEG, electroencephalography; REM, rapid eye movement.

a

Rett syndrome progresses from stage 1 where patients have a stagnation of developmental gains and normal to mildly slow background on EEG to a period of rapid developmental regression with increasingly abnormal EEG findings, and finally a plateau phase with stable developmental disability and signs of encephalopathy on EEG. Some patients progress to further motor deterioration and decreasing seizure burden with reduced epileptiform activity on EEG.